Revelation Biosciences REVB
NASDAQ REVB
$0.84 +0.02 (+2.43%)
As of: Oct 1, 2026 · 1:33 PM EDT

Revelation Biosciences (REVB) Preferred Dividend Payments (2025 - 2026)

Updated

Revelation Biosciences (REVB) recorded Preferred Dividend Payments of $5.68 million in Q1 2026.

Analysis

Revelation Biosciences (REVB) Preferred Dividend Payments (2025 - 2026) Analysis & Trends

For FY2025, Revelation Biosciences reported Preferred Dividend Payments of $5.95 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Revelation Biosciences 3.20 Mn -45.82 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 5.68 Mn
Sep 30, 2025 2.77 Mn
Jun 30, 2025 3.18 Mn
API Access

Revelation Biosciences Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=REVB&period=max&api_key=YOUR_API_KEY